Theriva Biologics, Inc. - Common stock (TOVX)

Historical Holders from Q3 2024 to Q3 2025

Symbol
TOVX on NYSE
CUSIP
87164U508
Type / Class
Equity / Common stock
Shares outstanding
9.6M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
437K
Holdings value
$177K
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
17
Number of buys
11
Number of sells
-6
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Theriva Biologics, Inc. - Common stock (TOVX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Jeffrey Matthew Gryga Irrevocable Trust 7.7% $296K 739K Jeffrey Matthew Gryga Irrevocable Trust Oct 24, 2025
Empery Asset Management, LP 4.99% -50% $202K -$180K 504K -47.1% Empery Asset Management, LP Sep 30, 2025
CVI Investments, Inc. 4.9% $167K 146K CVI Investments, Inc. Dec 31, 2024

Institutional Holders of Theriva Biologics, Inc. - Common stock (TOVX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 437K $177K +$57.4K $0.41 17
2025 Q2 291K $126K +$38.3K $0.43 15
2025 Q1 191K $210K +$166K $1.10 9
2024 Q4 34.5K $60K -$628K $1.75 9
2024 Q3 491K $678K +$472K $1.38 16